Samsung Bioepis Co., Ltd., a biopharmaceutical company committed to realizing healthcare that is accessible to everyone, and Biogen Inc., a leading biotechnology company, announced that the European ...
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...